Mentioned On
Episode Mentions
The Top Line · Jul 10, 2026
A $10B deal, China trial scrutiny and highlights from ADA 2026
“Pivoted from plant-based CDMO to metabolic medicine using AI-enabled drug discovery platform after Medicago closure”
Vertex Crinetics acquisition and rare endocrine disease expansionClinical trial regulation and China data integrity scrutinyGLP-1 agonist efficacy and weight loss outcomes
View Analysis
The Biotech Startups Podcast · May 7, 2026
🧬 Engineering a Drug Hunter: From Vet School to Big Pharma | Martin Brenner Rerelease (1/3)
“Martin's current role as CEO and CSO; uses AI drug discovery platform for immunotherapies targeting difficult-to-treat cancers”
AI-driven drug discovery platformsImmunotherapy development for difficult-to-treat cancersLeadership development in pharma and biotech
View Analysis